FLT3 and acute myeloid leukemia: Given the clinical significance of FLT3‐ITD, incorporating FLT3‐ITD fragment analysis into the AML diagnostic work‐up is a wise option to avoid missing a large FLT3‐ITD when using an amplicon‐based NGS panel.